BF.B
31
3
BA
49
-3
FITB
60
2
ILMN
37
5
XYL
45
8
NAVI
47
3
HPQ
57
-2
SO
57
2
ES
31
3
ROST
52
5
ISRG
76
2
PDCO
38
3
ROP
59
5
PRU
62
5
PPG
60
3
DTE
54
4
OKE
81
3
PCAR
56
3
BWA
46
2
KLAC
43
4
BF.B
31
3
BA
49
-3
FITB
60
2
ILMN
37
5
XYL
45
8
NAVI
47
3
HPQ
57
-2
SO
57
2
ES
31
3
ROST
52
5
ISRG
76
2
PDCO
38
3
ROP
59
5
PRU
62
5
PPG
60
3
DTE
54
4
OKE
81
3
PCAR
56
3
BWA
46
2
KLAC
43
4
Financhill
Back

Rocket Lab USA 10K Form

Buy
75

RKLB
Rocket Lab USA

Last Price:
23.26
Seasonality Move:
-6.44%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive RKLB News And Ratings

See the #1 stock for the next 7 days that we like better than RKLB

RKLB Financial Statistics

Sales & Book Value

Annual Sales: $244.59M
Cash Flow: $-41.93M
Price / Cash Flow: 0
Annual Sales: $0.84
Price / Book: 27.7

Profitability

EPS (TTM): -0.37000
Net Income (TTM): $-188.33M
Gross Margin: $51.41M
Return on Equity: -37.75%
Return on Assets: -17.39%

Rocket Lab USA Earnings Forecast

Key Rocket Lab USA Financial Ratios

  • The Gross Profit Margin over the past 4 years for RKLB is 21.02%.
  • The Selling, General & Administrative Expenses for RKLB have been equal to 45.08% of Gross Profit Margin.
  • The Research & Development expenses have been 48.67% of Revenue.
  • The Interest Expense is -5.74% of Operating Income.
  • The Net Earning history of RKLB is -74.64% of Total Revenues.
  • Per Share Earnings over the last 4 years have been positive in 1 years.

Rocket Lab USA Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Aerospace & Defense
Sector: Industrials
Current Symbol: RKLB
Website: rocketlabusa.com

Debt

Debt-to-Equity Ratio: 0.96
Current Ratio: 2.58
Quick Ratio: 1.95

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

RKLB Technical Analysis vs Fundamental Analysis

Buy
75
Rocket Lab USA (RKLB) is a Buy

Is Rocket Lab USA a Buy or a Sell?

  • Rocket Lab USA stock is rated a Buy
    The current Rocket Lab USA [RKLB] share price is $23.26. The Score for RKLB is 75, which is 50% above its historic median score of 50, and infers lower risk than normal.